摘要
嘌呤ATP有著名的监管作用,中枢神经系统功能和病理对胶质细胞由于其操作——小胶质细胞,星形胶质细胞和少突胶质细胞。ATP作为显然无处不在的“gliotransmitter”所发布的星形胶质细胞和其他细胞嘌呤受体激活邻近细胞。在病理学,ATP的释放中转组织损伤和修复由其直接作用于神经胶质细胞完整性和生存。ATP在神经胶质的行为是通过广泛的受体介导,大致分为ionotropic P2X和metabotropic(g蛋白耦合受体(GPCR))P2Y受体,其中有多个亚型(P2X1-P2X7和P2Y1-P2Y14)。ATP-mediated星形胶质细胞和小胶质细胞之间的相互作用在中枢神经系统的免疫反应的中心,突出角色P2X4,P2X7,P2Y1,P2Y6 P2Y12受体亚型。少突胶质细胞,P2X7 P2Y1受体亚型分别由两部分构成的函数在调停少突细胞破坏和保护。嘌呤受体调节胶质病理学,突出角色在缺血、神经炎症,多个Scelerosis、神经性疼痛和创伤性损伤。值得注意的是,神经胶质ATP信号可能与衰老和改变与髓鞘形成障碍和免疫在阿尔茨海默氏症。因此,胶质嘌呤受体在多种神经病理学提供潜在的治疗靶点,但Jeckyll和海德嘌呤信号的本质突显出进一步的研究的重要性,全面了解角色不同嘌呤受体在介导的组织损伤和修复。
关键词: 神经胶质. 星形胶质细胞. 少突胶质细胞.ATP. 嘌呤受体
Current Drug Targets
Title:A Central Role for ATP Signalling in Glial Interactions in the CNS
Volume: 17 Issue: 16
Author(s): Andrea Rivera, Ilaria Vanzulli, Arthur M. Butt
Affiliation:
关键词: 神经胶质. 星形胶质细胞. 少突胶质细胞.ATP. 嘌呤受体
摘要: The purine ATP has a prominent regulatory role in CNS function and pathology due to its actions on glial cells - microglia, astrocytes and oligodendrocytes. ATP serves as an apparently ubiquitous ‘gliotransmitter’ that is released by astrocytes and other cells to activate purine receptors on neighbouring cells. In pathology, the release of ATP mediates both tissue damage and repair by its direct effects on glial cell integrity and survival. The actions of ATP on glia are mediated via a wide range of receptors, broadly divided into ionotropic P2X and metabotropic (G-protein coupled receptors (GPCR)) P2Y receptors, of which there are multiple subtypes (P2X1-P2X7 and P2Y1-P2Y14). ATP-mediated interactions between astrocytes and microglia are at the centre of immune responses in the CNS, with prominent roles for the P2X4, P2X7, P2Y1, P2Y6 and P2Y12 receptor subtypes. In oligodendrocytes, P2X7 and P2Y1 receptor subtypes have a bipartite function in respectively mediating oligodendrocyte destruction and protection. Purine receptors mediate glial pathology, with prominent roles in ischemia, neuroinflammation, Multiple Scelerosis, neuropathic pain and traumatic injury. Notably, glial ATP signalling may be altered with ageing and is implicated in impaired myelination and immunity in Alzheimer’s disease. Hence, glial purine receptors provide potential therapeutic targets in multiple neuropathologies, but the ‘Jeckyll and Hyde’ nature of purine signalling underscores the importance of further research and a comprehensive understanding of the roles of the different purine receptors in mediating tissue damage and repair.
Export Options
About this article
Cite this article as:
Andrea Rivera, Ilaria Vanzulli, Arthur M. Butt , A Central Role for ATP Signalling in Glial Interactions in the CNS, Current Drug Targets 2016; 17 (16) . https://dx.doi.org/10.2174/1389450117666160711154529
DOI https://dx.doi.org/10.2174/1389450117666160711154529 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
Drug-Targeted Approach with Polymer Nanocomposites for Improved Therapeutics
Polymer nanocomposites have been recognized as an advanced and cutting-edge technique in drug targeting administration. These materials combine the unique features of nanoparticles with the adaptability of polymers to produce highly personalized drug administration devices. Integrating nanoparticles containing pharmaceuticals into a polymer matrix enables researchers to regulate the rates at ...read more
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
Therapeutic Chemical and RNA Design with Artificial Intelligence
Computer-Aided Drug Design (CADD) has emerged as a fundamental component of modern drug discovery. Molecular docking facilitates virtual screening on a large scale through structural simulations. However, traditional CADD approaches face significant limitations, as they can only screen known compounds from existing libraries. PubChem, as the most widely used chemical ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pharmacological Countermeasures for the Acute Radiation Syndrome
Current Molecular Pharmacology Cytoskeletal Pathologies of Age-Related Diseases between Elderly Sri Lankan (Colombo) and Indian (Bangalore) Brain Samples
Current Alzheimer Research Pain and Child: A Translational Hypothesis on the Pathophysiology of a Mild Type-2 Diabetes Model
Endocrine, Metabolic & Immune Disorders - Drug Targets Hypoxia as an Initiator of Neuroinflammation: Microglial Connections
Current Neuropharmacology Oleanolic Acid Ameliorates Aβ25-35 Injection-induced Memory Deficit in Alzheimer’s Disease Model Rats by Maintaining Synaptic Plasticity
CNS & Neurological Disorders - Drug Targets Apolipoprotein A-I/HDL Infusion Therapy for Plaque Stabilization-Regression: A Novel Therapeutic Approach
Current Pharmaceutical Design Neuroprotective Mechanisms of Oxygen and Ethanol: A Potential Combination Therapy in Stroke
Current Medicinal Chemistry Neuropsychiatric Systemic Lupus Erythematosus
Current Neuropharmacology The Pleiotropic Effects of Inducible Nitric Oxide Synthase (iNOS) on the Physiology and Pathology of Penile Erection
Current Pharmaceutical Design Control of Stemness by Fibroblast Growth Factor Signaling in Stem Cells and Cancer Stem Cells
Current Stem Cell Research & Therapy Astragaloside IV Supplementation Promotes A Neuroprotective Effect in Experimental Models of Neurological Disorders: A Systematic Review
Current Neuropharmacology Chemistry and Pharmacology of Bioactive Molecule -Coenzyme Q10: A Brief Note
Current Bioactive Compounds Self-assembling Peptides in Current Nanomedicine: Versatile Nanomaterials for Drug Delivery
Current Medicinal Chemistry A Practical Guide for the Treatment of Symptomatic Heart Failure with Reduced Ejection Fraction (HFrEF)
Current Cardiology Reviews Time Dependent Distribution of MicroRNA 144 after Intravenous Delivery
MicroRNA COX-2 Inhibitors and Cardiovascular Events: Deja Vu Du Jour
Vascular Disease Prevention (Discontinued) Properties and Therapeutic Potential of Transient Receptor Potential Channels with Putative Roles in Adversity: Focus on TRPC5, TRPM2 and TRPA1
Current Drug Targets Endocrine Disruptors and Human Health
Mini-Reviews in Medicinal Chemistry Effect of Doxycycline on Atherosclerosis: From Bench to Bedside
Recent Patents on Cardiovascular Drug Discovery Vicious Cycles Within the Neuropathophysiologic Mechanisms of Alzheimers Disease
Current Alzheimer Research